Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors. | Molecules | 2023 | 37049983 | PubTator, text mining | PubMed |
| Safety and feasibility of laparoscopic liver resection for intrahepatic cholangiocarcinoma: a propensity score-matched study. | World J Surg Oncol | 2023 | 37032348 | PubTator, text mining | PubMed |
| Identification of key genes and potential mechanisms based on the autophagy regulatory network in intervertebral disc degeneration. | Medicine (Baltimore) | 2023 | 37026912 | PubTator, text mining | PubMed |
| Carbonic anhydrase IX-related tumoral hypoxia predicts worse prognosis in breast cancer: A systematic review and meta-analysis. | Front Med (Lausanne) | 2023 | 37007798 | PubTator, text mining | PubMed |
| CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment. | Front Immunol | 2023 | 37006233 | PubTator, text mining | PubMed |
| Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors. | Int J Biol Macromol | 2023 | 37001773 | PubTator, text mining | PubMed |
| Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα. | Pharmaceuticals (Basel) | 2023 | 36986441 | PubTator, text mining | PubMed |
| Differential CMS-Related Expression of Cell Surface Carbonic Anhydrases IX and XII in Colorectal Cancer Models-Implications for Therapy. | Int J Mol Sci | 2023 | 36982873 | PubTator, text mining | PubMed |
| Exploring the Role of Hypoxia-Inducible Carbonic Anhydrase IX (CAIX) in Circulating Tumor Cells (CTCs) of Breast Cancer. | Biomedicines | 2023 | 36979915 | PubTator, text mining | PubMed |
| Skin-Interfaced Wearable Sweat Sensors for Precision Medicine. | Chem Rev | 2023 | 36971504 | PubTator, text mining | PubMed |
| Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors. | J Enzyme Inhib Med Chem | 2023 | 36938694 | PubTator, text mining | PubMed |
| The Multifarious Effects of Various Glaucoma Pharmacotherapy on Corneal Endothelium: A Narrative Review. | Ophthalmol Ther | 2023 | 36930417 | PubTator, text mining | PubMed |
| Expression of pH-Sensitive GPCRs in Peritoneal Carcinomatosis of Colorectal Cancer-First Results. | J Clin Med | 2023 | 36902589 | PubTator, text mining | PubMed |
| Phytochemical Profiling of Extracts from Rare Potentilla Species and Evaluation of Their Anticancer Potential. | Int J Mol Sci | 2023 | 36902263 | PubTator, text mining | PubMed |
| Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD. | Respir Res | 2023 | 36899372 | PubTator, text mining | PubMed |
| Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer. | Front Oncol | 2023 | 36890820 | PubTator, text mining | PubMed |
| Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties. | J Enzyme Inhib Med Chem | 2023 | 36880350 | PubTator, text mining | PubMed |
| Synthesis and biological evaluation of new 3-substituted coumarin derivatives as selective inhibitors of human carbonic anhydrase IX and XII. | J Enzyme Inhib Med Chem | 2023 | 36876597 | PubTator, text mining | PubMed |
| Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells. | Comput Struct Biotechnol J | 2023 | 36874158 | PubTator, text mining | PubMed |
| Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffold. | Drug Dev Res | 2023 | 36872587 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=12